The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amendment to a Schedule 13G reporting shared voting and shared dispositive power in ACADIA HEALTHCARE COMPANY, INC. The cover data shows shared voting power of 1,453,488.72 shares, shared dispositive power of 1,454,430.72 shares and a reported total of 1,464,125.72 shares representing 1.6% of the class as of 03/31/2026. The filing is a joint filing under a Joint Filing Agreement signed by Sam Prashanth on 04/24/2026.
Positive
None.
Negative
None.
Insights
Large broker-dealer reported a modest passive stake in ACHC.
The filing shows that The Goldman Sachs Group, Inc. and its subsidiary listed combined shared voting power of 1,453,488.72 shares and shared dispositive power of 1,454,430.72 shares, equal to 1.6% of the class as of 03/31/2026. The numbers are disclosed on an amended Schedule 13G/A and accompanied by a joint filing agreement executed on 04/24/2026.
These holdings are presented as passive in nature under the Schedule 13G framework; cash‑flow treatment and any trading intent are not specified in the excerpt. Subsequent filings or exhibits may clarify which subsidiary accounts hold these shares and whether any positions are client‑related.
Key Figures
Report date:03/31/2026Shared voting power:1,453,488.72 sharesShared dispositive power:1,454,430.72 shares+3 more
6 metrics
Report date03/31/2026cover page "03/31/2026"
Shared voting power1,453,488.72 sharescover page shared voting power
Shared dispositive power1,454,430.72 sharescover page shared dispositive power
Total reported shares1,464,125.72 sharescover page total shown
Percent of class1.6%cover page Item 11 percentage
Signature date04/24/2026Joint Filing Agreement signature date
"amendment to a Schedule 13G reporting shared voting and shared dispositive power"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
shared dispositive powerfinancial
"Shared Dispositive Power 1,454,430.72"
Joint Filing Agreementregulatory
"EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)"
beneficially ownedfinancial
"this filing reflects the securities beneficially owned by certain operating units"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
What stake does Goldman Sachs report in ACADIA HEALTHCARE (ACHC)?
Goldman Sachs reports a 1.6% stake represented by 1,464,125.72 shares. The Schedule 13G/A shows shared voting power of 1,453,488.72 shares and shared dispositive power of 1,454,430.72 shares as of 03/31/2026.
Who signed the joint filing agreement for ACHC?
The joint filing agreement was signed by Sam Prashanth as Attorney-in-fact. The agreement is filed as Exhibit (99.1) and the signatures are dated 04/24/2026 in the amendment.
Does this amendment state whether Goldman Sachs' holdings are discretionary or client-owned?
The filing disclaims beneficial ownership for certain client accounts and identifies Goldman Sachs & Co. LLC as a reporting subsidiary. Exhibit (99.3) and the Item 4 disclosure reference client and entity exceptions per Release No. 34-39538.
Are the reported shares owned solely by Goldman Sachs or shared among affiliates?
The reported voting and dispositive powers are shown as shared powers, not sole powers. The cover shows zero sole voting and sole dispositive power and lists the holdings under shared voting and shared dispositive power columns.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
ACADIA HEALTHCARE COMPANY, INC.
(Name of Issuer)
Common stock, $.01 par value
(Title of Class of Securities)
00404A109
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
00404A109
1
Names of Reporting Persons
THE GOLDMAN SACHS GROUP, INC.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,453,488.72
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,454,430.72
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,464,125.72
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.6 %
12
Type of Reporting Person (See Instructions)
HC, CO
SCHEDULE 13G
CUSIP Number(s):
00404A109
1
Names of Reporting Persons
GOLDMAN SACHS & CO. LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NEW YORK
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,453,488.72
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,454,430.72
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,464,125.72
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.6 %
12
Type of Reporting Person (See Instructions)
BD, OO, IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
ACADIA HEALTHCARE COMPANY, INC.
(b)
Address of issuer's principal executive offices:
4020 ASPEN GROVE DR STE 900, FRANKLIN, X1, 37067
Item 2.
(a)
Name of person filing:
THE GOLDMAN SACHS GROUP, INC.| GOLDMAN SACHS & CO. LLC
(b)
Address or principal business office or, if none, residence:
The Goldman Sachs Group, Inc. 200 West Street New York, NY 10282| Goldman Sachs & Co. LLC 200 West Street New York, NY 10282
(c)
Citizenship:
THE GOLDMAN SACHS GROUP, INC. - Delaware| GOLDMAN SACHS & CO. LLC - New York
(d)
Title of class of securities:
Common stock, $.01 par value
(e)
CUSIP No.:
00404A109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See the response(s) to Item 9 on the attached cover page(s).
(b)
Percent of class:
See the response(s)to Item 11 on the attached cover page(s).
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s).
(ii) Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the attached cover page(s).
(iii) Sole power to dispose or to direct the disposition of:
See the response(s) to Item 7 on the attached cover page(s).
(iv) Shared power to dispose or to direct the disposition of:
See the response(s) to Item 8 on the attached cover page(s).
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Exhibit (99.2)
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
THE GOLDMAN SACHS GROUP, INC.
Signature:
Name: Sam Prashanth
Name/Title:
Attorney-in-fact
Date:
04/24/2026
GOLDMAN SACHS & CO. LLC
Signature:
Name: Sam Prashanth
Name/Title:
Attorney-in-fact
Date:
04/24/2026
Exhibit Information
EXHIBIT (99.1)
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities
Exchange Act of 1934, the undersigned agree to the joint filing of a Statement
on Schedule 13G (including any and all amendments thereto) with respect to the
Common stock, $.01 par value, par value $ per share, of ACADIA HEALTHCARE COMPANY, INC.
and further agree to the filing of this agreement as an Exhibit thereto.
In addition, each party to this Agreement expressly authorizes each other party
to this Agreement to file on its behalf any and all amendments to such Statement
on Schedule 13G.
Date:
THE GOLDMAN SACHS GROUP, INC.
By:/s/ Sam Prashanth
----------------------------------------
Name: Sam Prashanth
Title: Attorney-in-fact
GOLDMAN SACHS & CO. LLC
By:/s/ Sam Prashanth
----------------------------------------
Name: Sam Prashanth
Title: Attorney-in-fact
EXHIBIT (99.2)
ITEM 7 INFORMATION
The securities being reported on by The Goldman Sachs Group, Inc.
("GS Group"), as a parent holding company, are owned, or may be deemed to be
beneficially owned, by Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or
dealer registered under Section 15 of the Act and an investment adviser
registered under Section 203 of the Investment Advisers Act of 1940. Goldman
Sachs is a subsidiary of GS Group.
EXHIBIT (99.3)
ITEM 4 INFORMATION
*In accordance with the Securities and Exchange Commission Release No.
34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities
beneficially owned by certain operating units (collectively, the "Goldman Sachs
Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and
affiliates (collectively, "GSG"). This filing does not reflect securities, if
any, beneficially owned by any operating units of GSG whose ownership of
securities is disaggregated from that of the Goldman Sachs Reporting Units in
accordance with the Release. The Goldman Sachs Reporting Units disclaim
beneficial ownership of the securities beneficially owned by (i) any client
accounts with respect to which the Goldman Sachs Reporting Units or their
employees have voting or investment discretion or both, or with respect to
which there are limits on their voting or investment authority or both and
(ii) certain investment entities of which the Goldman Sachs Reporting Units
act as the general partner, managing general partner or other manager, to the
extent interests in such entities are held by persons other than the Goldman
Sachs Reporting Units.
